Pulse Biosciences, Inc. PLSE Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $68.32M-42.7% | $80.74M-31.6% | $95.21M+20.5% | $106.35M+306% | $119.28M+242% | ||
| —— | —— | —— | —— | —— | ||
| $450K+1,400% | $274K— | $138K— | $81K— | $30K— | ||
| $2.45M+53.0% | $2.28M+61.3% | $1.87M+35.5% | $1.76M+68.7% | $1.6M+66.0% | ||
| $71.13M-41.2% | $83.42M-30.2% | $97.16M+20.8% | $108.16M+297% | $120.91M+237% | ||
| $1.02M-4.3% | $1.05M-9.4% | $1.06M-13.6% | $1.11M-15.5% | $1.06M-24.1% | ||
| $5.7M-17.2% | $6.01M-16.1% | $6.32M-4.1% | $6.32M-7.4% | $6.89M-2.1% | ||
| $2.79M0.0% | $2.79M0.0% | $2.79M0.0% | $2.79M0.0% | $2.79M0.0% | ||
| $408K-61.3% | $575K-52.9% | $741K-46.5% | $907K-41.6% | $1.05M-38.7% | ||
| $575K-15.2% | $691K+2.1% | $705K+9.1% | $677K-5.2% | $678K+85.8% | ||
| $81.62M-38.8% | $94.54M-28.6% | $108.77M+16.9% | $120.25M+197% | $133.38M+171% | ||
| $2.76M+16.5% | $2.78M+66.0% | $2.98M+72.4% | $2.74M+67.5% | $2.37M+38.4% | ||
| $5.41M+35.7% | $3.58M-49.1% | $5.2M+36.2% | $4.78M+50.3% | $3.98M+75.7% | ||
| $1.63M+15.7% | $1.57M+15.9% | $1.52M+27.3% | $1.46M+27.3% | $1.41M+27.7% | ||
| $9.8M+26.2% | $7.92M-21.2% | $9.7M+43.9% | $8.98M+50.6% | $7.76M+52.7% | ||
| $5.53M-22.9% | $5.96M-21.0% | $6.37M-11.2% | $6.79M-9.5% | $7.17M-8.0% | ||
| $15.32M+2.6% | $13.88M-21.1% | $16.07M+15.5% | $15.76M+17.1% | $14.93M+16.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $68K+1.5% | $68K+3.0% | $68K+9.7% | $67K+21.8% | $67K+21.8% | ||
| $548.09M+4.3% | $543.87M+7.6% | $538.47M+19.6% | $530.88M+37.8% | $525.68M+37.2% | ||
| -$481.86M-18.3% | -$463.28M-18.6% | -$445.85M-20.1% | -$426.46M-19.0% | -$407.3M-17.4% | ||
| $66.3M-44.0% | $80.66M-29.8% | $92.69M+17.1% | $104.49M+287% | $118.45M+226% | ||
| $81.62M-38.8% | $94.54M-28.6% | $108.77M+16.9% | $120.25M+197% | $133.38M+171% | ||
| $575K-15.2% | $691K+2.1% | $705K+9.1% | $677K-5.2% | $678K+85.8% | ||
| $5.7M-17.2% | $6.01M-16.1% | $6.32M-4.1% | $6.32M-7.4% | $6.89M-2.1% | ||
| $408K-61.3% | $575K-52.9% | $741K-46.5% | $907K-41.6% | $1.05M-38.7% | ||
| $5.7M-17.2% | $6.01M-16.1% | $6.32M-4.1% | $6.32M-7.4% | $6.89M-2.1% | ||
| $575K-15.2% | $691K+2.1% | $705K+9.1% | $677K-5.2% | $678K+85.8% | ||
| $5.7M-17.2% | $6.01M-16.1% | $6.32M-4.1% | $6.32M-7.4% | $6.89M-2.1% | ||
| $575K-15.2% | $691K+2.1% | $705K+9.1% | $677K-5.2% | $678K+85.8% | ||
| $5.41M+35.7% | $3.58M-49.1% | $5.2M+36.2% | $4.78M+50.3% | $3.98M+75.7% | ||
| $5.41M+35.7% | $3.58M-49.1% | $5.2M+36.2% | $4.78M+50.3% | $3.98M+75.7% | ||
| $7.16M-16.6% | $7.53M-15.4% | $7.89M-5.7% | $8.25M-4.6% | $8.58M-3.6% | ||
| $548.09M+4.3% | $543.87M+7.6% | $538.47M+19.6% | $530.88M+37.8% | $525.68M+37.2% | ||
| $68K+1.5% | $68K+3.0% | $68K+9.7% | $67K+21.8% | $67K+21.8% | ||
| $0— | $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulse Biosciences, Inc.'s total assets?
- Pulse Biosciences, Inc. (PLSE) holds $81.6M in total assets, down 38.8% year over year.
- How much debt does Pulse Biosciences, Inc. have?
- Pulse Biosciences, Inc. carries $7.2M in total debt against $66.3M of shareholders' equity, a debt-to-equity ratio of 0.11.
- How much cash does Pulse Biosciences, Inc. have?
- Pulse Biosciences, Inc. holds $68.3M in cash and equivalents.
- Can Pulse Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 7.26 — current assets exceed current liabilities.
- Where does Pulse Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
